| IPO Company Profile |
| Current Quote | News | SEC Filings | Peer IPO Companies |
| Bioshield Technologies, Inc. |
| 4405 International Boulevard, Suite B-109, Norcross, GA 30093 * (770) 925-3432 |
| The company is a developmental stage company engaged in the development, marketing and sale of surface modifying antimicrobials and biostatic products, primarily through third party licensing arrangements. |
| Manager | Tier | Phone |
| Tejas Securities Group | Lead Manager | |
| Redstone Securities, Inc. | Co-manager | (800) 426-7346 |
| Seaboard Securities, Inc. | Co-manager | (201) 514-1500 |
| NASSCM: | BSTI | Manufacturing: | SIC 2842 | |
| Type of Shares: | Common Shares | Filing Date: | 6/26/98 | |
| U.S. Shares: | 1,300,000 | Offer Date: | 9/30/98 | |
| Non-U.S. Shares: | 0 | Filing Range: | $5.50 - $6.50 | |
| Primary Shares: | 1,300,000 | Offer Price: | $5.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.50 | |
| Offering Amount: | $7,800,000 | Selling: | $0.22 | |
| Expenses: | $500,000 | Reallowance: | $0.08 | |
| Post-IPO Shares: | 5,895,040 | |||
| Employees: | 7 |
| Issuer's Law Firm: | Sims Moss Kline & Davis LLP |
| Bank's Law Firm: | Winstead Sechrest & Minick |
| Registrar/Transfer Agent: | American Stock Transfer & Trust Co |
| Auditor: | Grant Thornton |
Dollar amounts in U.S. millions except for per share data | |||||
| 11 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Audited Income | Balance Sheet | ||
| 7/30/97 | 5/31/98 | 5/31/97 | 5/31/98 | ||
| Revenue: | $0.78 | $0.43 | $0.58 | Assets: | $0.47 |
| Net Income: | -$0.51 | -$1.19 | -$0.61 | Curr Assets: | $0.30 |
| EPS: | $0.12 | $0.27 | $0.16 | Liabilities: | $1.25 |
| Prior EPS: | $0.09 | Curr Liab: | $1.25 | ||
| Cash Flow/Oper: | -$0.43 | -$1.12 | -$0.58 | Equity: | -$0.78 |
| Cash Flow/Fin: | $0.85 | $0.82 | $0.85 | Cash: | $0.02 |
| Cash Flow/Inv: | -$0.05 | -$0.08 | -$0.05 | Working Cap: | -$0.95 |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to payoff existing noteholder indebtedness, EPA testing, FDA updates, research and development, marketing, and working capital and for general corporate purposes. |
| Additional Underwriter Compensation |
| Warrant to purchase 150,000 shares/units at a nominal price. |
| # of Units: | 750,000 | |||
| Unit Ticker: | BSTIU | Unit Price: | $13.00 | |
| Warrant Ticker: | BSTIW | Warrant Price: | ||
| Warrant Exercise Date: | Warrant Exercise Price: | $7.80 | ||
| Warrant Expiration Date: | ||||
| Warrant Detachable: | Yes | Warrant Detach Date: | ||
| Warrant Callable: | No |
| Unit Composition: 2 Common Shares + 1 Warrant |
| Warrant Entitlement: 1 Common Share |